trifluoromethylbamino
alcohol
tertbutyl
synthes
five
step
start
cbzlgluoh
key
step
involv
introduct
trifluoromethyl
cf
group
oxazolidinon
result
format
silyl
ether
benzyl
tertbutoxycarbonyl
ethyl
trifluoromethyl
trimethylsilyloxi
compound
convert
four
triand
tetraglutam
acid
glutamin
peptid
possess
cf
keton
group
exhibit
inhibitori
activ
sever
acut
respiratori
syndrom
coronaviru
proteas
sarscov
pro
may
two
group
report
novel
coronaviru
cov
caus
agent
sever
acut
respiratori
syndrom
sar
cov
encod
chymotrypsinlik
proteas
pro
play
pivot
role
replic
viru
pro
function
analog
main
picornaviru
proteas
pro
cystein
proteas
catalyt
dyad
activ
site
cy
nucleophil
gener
base
although
global
sar
crisi
avoid
infect
contain
still
matter
necess
find
compound
inhibit
sarscov
case
diseas
might
reemerg
compound
contain
trifluoromethyl
keton
cf
moieti
form
import
group
biolog
use
fluorin
molecul
use
proteas
inhibitor
first
describ
abel
et
al
cf
group
next
carbonyl
group
thermodynam
stabil
hemiket
form
rel
keton
form
thu
make
carbonyl
prone
nucleophil
substitut
water
activ
site
ser
hydroxyl
cy
thiol
group
present
serin
cystein
proteas
nucleophil
attack
activ
site
thiol
sarscov
pro
would
convert
cf
keton
tetrahedr
adduct
b
scheme
believ
mimic
substrateenzym
intermedi
form
substrat
peptidebond
hydrolysi
sinc
adduct
b
rel
stabl
compound
would
behav
proteas
inhibitor
suggest
compound
contain
cf
keton
moieti
may
play
import
role
pro
inhibitor
cf
keton
also
form
rel
stabl
hydrat
adduct
c
upon
react
water
uniqu
conserv
recognit
substrat
gln
residu
p
site
identifi
cov
cystein
proteas
famili
therefor
glnderiv
cf
keton
residu
would
contribut
activ
sarscov
pro
inhibitor
base
consider
new
synthet
method
form
gln
glu
deriv
possess
cf
keton
moieti
develop
strategi
use
synthesi
four
peptid
compound
keyword
trifluoromethyl
keton
proteas
inhibitor
sever
acut
respiratori
syndrom
coronaviru
proteas
sarscov
pro
target
compound
envis
synthes
two
part
viz
peptid
part
bamino
alcohol
contain
cf
unit
two
part
would
coupl
togeth
elabor
desir
target
compound
synthesi
key
compound
start
oxazolidinon
acid
prepar
cbzlgluoh
condit
describ
moor
et
al
result
acid
convert
tertbutyl
ester
expedi
convert
silyl
ether
yield
scheme
isol
singl
diastereom
determin
h
c
nmr
analys
util
literatur
method
depict
stereochemistri
compound
base
literatur
preced
similar
compound
addit
cf
anion
anti
side
chain
product
readili
desilyl
upon
treatment
tetrabutylammonium
fluorid
tbaf
give
alcohol
yield
observ
compound
partli
convert
desilyl
product
expos
air
caus
partial
protiodesilyl
might
due
moisturesensit
natur
compound
patent
literatur
one
report
desilyl
occur
upon
stir
similar
compound
methanol
like
caus
water
present
methanol
substrat
found
method
proceed
reaction
carri
small
scale
mg
less
howev
ad
water
methanol
methanolwat
vv
substrat
could
fulli
convert
compound
h
stir
room
temperatur
scheme
compound
also
convert
correspond
alcohol
yield
onepot
reaction
ad
small
amount
water
reaction
mixtur
intermedi
follow
sonic
addit
half
hour
final
desir
alcohol
obtain
treat
compound
nabh
methanol
room
temperatur
gave
target
compound
ca
mixtur
diastereom
determin
h
c
nmr
analys
yield
among
differ
synthet
rout
tri
treat
methanol
solut
silyl
ether
nabh
seem
effici
rout
synthes
alcohol
condit
obtain
desir
compound
yield
scheme
final
protect
group
within
substrat
could
easili
cleav
hydrogen
pdc
afford
alcohol
quantit
yield
coupl
peptid
bamino
alcohol
gave
expect
amid
scheme
use
directli
next
step
afford
keton
peptid
subject
exactli
reaction
sequenc
give
keton
treat
compound
trifluoroacet
acid
tfa
result
clean
remov
tertbutyl
group
form
tripeptid
examin
c
nmr
spectrum
reveal
inhibitor
exist
predominantli
hydrat
form
cdcl
contain
one
drop
dmsod
f
nmr
analysi
sampl
show
hydrat
form
domin
tautom
sampl
two
possibl
tautomer
form
tripeptid
also
present
small
amount
equilibrium
differ
tautomer
form
compound
might
shift
depend
solvent
due
small
amount
compound
avail
decid
studi
detail
use
simpler
model
compound
vide
infra
compound
subject
exactli
reaction
condit
ester
afford
peptid
remain
crude
tripeptid
peptid
subject
directli
coupl
condit
outlin
scheme
method
thu
give
product
yield
four
step
respect
hplc
purif
low
chemic
yield
target
compound
result
last
reaction
sequenc
seem
ineffici
give
rise
mani
side
product
effort
improv
yield
last
step
compound
prepar
mix
anhydrid
strategi
use
slightli
modifi
literatur
procedur
method
b
mean
abl
improv
overal
yield
inhibitor
peptid
f
nmr
studi
three
glutamin
peptid
show
compound
exist
cyclic
form
tripeptid
ca
mixtur
cyclic
keto
form
cdcl
recent
similar
observ
report
glutamin
fluoromethyl
keton
cai
et
al
previous
also
report
glutamin
compound
mostli
exist
hemiamin
organ
solvent
previous
note
target
peptid
predominantli
present
hydrat
form
cdcl
howev
allud
previou
section
might
differ
depend
solvent
use
nmr
studi
therefor
decid
synthes
acid
much
simpler
molecul
real
system
nevertheless
thought
good
model
studi
end
alcohol
convert
keton
yield
ca
mixtur
keto
hydrat
form
evid
f
c
nmr
analys
scheme
attempt
convert
compound
free
acid
result
format
decomposit
product
lack
stabil
desir
model
compound
forc
us
use
slightli
complex
acid
studi
compound
synthes
threestep
process
outlin
scheme
first
coupl
cbzlalaoh
amin
gave
desir
alcohol
directli
oxid
keton
yield
two
step
c
f
nmr
analys
keton
becam
evid
keton
exist
ca
mixtur
hydrat
keto
form
rather
unstabl
keton
deprotect
give
dipeptid
almost
quantit
yield
ca
puriti
determin
hplc
analysi
c
nmr
spectrum
suggest
compound
exist
mostli
cyclic
hemiacet
cdcl
reson
shift
ppm
also
case
c
nmr
spectrum
obtain
sampl
cd
od
nmr
studi
model
compound
predomin
keto
hydrat
hemiacet
form
respect
support
assign
compound
exist
mainli
hydrat
form
cdcl
evid
deriv
f
c
nmr
spectra
keton
present
mixtur
keto
hydrat
form
work
model
compound
also
suggest
form
acid
appear
solut
highli
solventand
concentrationdepend
inhibitori
activ
target
compound
sarscov
pro
test
use
fluorescencebas
peptid
cleavag
assay
tabl
origin
thought
glutamin
peptid
compound
would
potent
inhibitor
assay
howev
glutamatepossess
inhibitor
potent
group
conform
compound
exist
interact
activ
site
sarscov
pro
believ
contribut
bind
affin
cai
cowork
found
gln
fluoromethyl
keton
exhibit
low
activ
assay
fact
explain
refer
inhibitor
predominantli
exist
cyclic
form
evid
nmr
studi
expect
interact
effect
activ
site
sarscov
gln
compound
synthes
studi
also
found
mainli
cyclic
form
may
explain
low
biolog
activ
compound
howev
glu
inhibitor
found
mainli
exist
hydrat
form
form
like
interact
effect
activ
site
simpl
fivestep
procedur
synthesi
bamino
alcohol
contain
cf
group
develop
alcohol
elabor
four
triand
tetraglu
gln
peptid
compound
found
moder
sarscov
pro
inhibitor
current
work
focus
cocrystal
compound
sarscov
pro
attempt
elucid
mode
action
melt
point
measur
yanagimoto
micro
hotstag
apparatu
uncorrect
proton
h
carbon
c
nmr
spectra
record
either
jeol
spectromet
oper
mhz
proton
mhz
carbon
varian
uniti
inova
spectromet
oper
mhz
proton
mhz
carbon
chemic
shift
record
valu
part
per
million
ppm
downfield
tetramethylsilan
tm
fluorin
f
nmr
spectra
record
varian
uniti
inova
spectromet
oper
mhz
fluorin
fluorin
nmr
spectra
referenc
extern
c
f
ppm
lowresolut
mass
spectra
esi
record
finnigan
spectrophotomet
lowand
highresolut
mass
spectra
fab
record
jeol
spectromet
equip
data
system
lowand
highresolut
mass
spectra
ci
record
jeol
jmsgcmate
optic
rotat
measur
horiba
highspe
accur
polarimet
sodiumd
line
nm
concentr
c
g
ml
measur
carri
c
cell
path
length
l
dm
specif
rotat
given
deg
cm
g
prepar
hplc
carri
revers
phase
column
mm
ymc
pack
od
binari
solvent
system
linear
gradient
ch
cn
aq
tfa
flow
rate
ml
min
detect
nm
analyt
hplc
perform
use
revers
phase
column
mm
ymc
pack
od
binari
solvent
system
linear
gradient
ch
cn
aq
tfa
flow
rate
ml
min
detect
nm
r
given
target
compound
obtain
analyt
hplc
solvent
use
hplc
hplc
grade
chemic
analyt
grade
better
onepot
synthesi
compound
compound
method
c
cesium
fluorid
mg
mmol
trifluoromethyl
trimethylsilan
ml
mmol
ad
solut
oxazolidinon
mg
mmol
dri
thf
ml
maintain
argon
atmospher
reaction
mixtur
sonic
h
ambient
temperatur
water
ml
ad
reaction
mixtur
sonic
addit
h
reaction
mixtur
dilut
etoac
ml
wash
water
ml
brine
ml
dri
mgso
filtrat
concentr
reduc
pressur
gave
titl
alcohol
mg
ident
respect
materi
obtain
via
stepwis
method
tertbutyl
benzyloxycarbonyl
sodium
borohydrid
g
mmol
ad
stir
solut
alcohol
g
mmol
thf
ml
atmospher
argon
result
reaction
mixtur
stir
h
quench
addit
water
ml
water
phase
extract
etoac
ml
combin
organ
fraction
dri
mgso
filtrat
concentr
reduc
pressur
gave
lightyellow
oil
subject
flash
chromatographi
silica
hexaneetoac
eluent
concentr
relev
fraction
r
f
gave
titl
alcohol
reaction
mixtur
allow
heat
room
temperatur
stir
h
concentr
reduc
pressur
result
substrat
dissolv
etoac
ml
wash
citric
acid
ml
aq
solut
brine
ml
dri
na
filtrat
concentr
reduc
pressur
gave
lightyellow
solid
recrystal
hexaneetoac
give
titl
protect
peptid
edc
hcl
mg
mmol
ad
stir
solut
relev
protect
peptid
mmol
dmf
ml
c
reaction
mixtur
stir
min
amin
mg
mmol
dissolv
dmf
ml
ad
dropwis
reaction
mixtur
allow
heat
room
temperatur
stir
h
dmf
remov
reduc
pressur
result
residu
dilut
etoac
ml
wash
citric
acid
ml
aq
solut
nahco
ml
aq
solut
brine
ml
dri
na
filtrat
concentr
reduc
pressur
gave
desir
compound
quantit
yield
crude
product
contain
small
amount
impur
use
next
step
without
purif
product
satisfactori
lowresolut
mass
spectra
oxid
dessmartin
periodinan
mg
mmol
ad
stir
solut
relev
peptid
previou
step
ch
cl
ml
c
result
reaction
mixtur
allow
heat
room
temperatur
stir
h
filter
plug
celit
wash
afterward
etoac
ml
concentr
reduc
pressur
gave
desir
compound
yellow
oil
materi
use
next
step
without
purif
product
satisfactori
lowresolut
mass
spectra
deprotect
tfa
ml
mmol
ad
dropwis
stir
solut
relev
compound
previou
step
ch
cl
ml
c
reaction
mixtur
allow
heat
room
temperatur
stir
h
concentr
reduc
pressur
crude
product
use
directli
next
step
without
purif
except
small
amount
crude
peptid
purifi
stage
order
provid
sampl
biolog
assay
reaction
mixtur
allow
heat
room
temperatur
stir
h
dmf
remov
reduc
pressur
residu
thu
obtain
dissolv
etoac
ml
wash
citric
acid
ml
aq
solut
nahco
ml
aq
solut
brine
ml
dri
na
filtrat
concentr
reduc
pressur
gave
crude
product
purifi
prepar
hplc
concentr
relev
fraction
gave
desir
compound
yield
state
dessmartin
periodinan
mg
mmol
ad
stir
solut
alcohol
mg
ch
cl
ml
room
temperatur
reaction
mixtur
stir
h
dilut
etoac
ml
filter
plug
celit
wash
etoac
ml
concentr
reduc
pressur
gave
lightyellow
oil
subject
flash
chromatographi
silica
hexaneetoacet
n
eluent
concentr
relev
fraction
r
f
hexaneetoac
gave
titl
compound
mg
two
step
clear
colorless
oil
ca
mixtur
hydrat
keto
form
judg
h
f
nmr
analys
tautom
exist
ca
mixtur
rotam
judg
h
tfa
ml
mmol
ad
dropwis
solut
ester
mg
mmol
ch
cl
ml
room
temperatur
reaction
mixtur
stir
room
temperatur
h
concentr
reduc
pressur
give
titl
compound
mg
crude
yield
yellow
oil
ca
pure
judg
hplc
analysi
ca
mixtur
cyclic
keto
hydrat
form
judg
f
nmr
analysi
cyclic
form
exist
ca
mixtur
rotam
judg
signal
due
cf
group
carbon
could
discern
one
signal
obscur
overlap
f
nmr
mhz
cdcl
cyclic
cyclic
keto
hydrat
hydrat
hydrat
hydrat
appear
four
signal
hydrat
form
compound
f
nmr
probabl
due
partial
racem
time
posit
compound
extent
racem
time
f
nmr
measur
less
ms
mz
inhibitori
assay
perform
use
commerci
avail
fluorogen
substrat
dabcylktsavlqsgfrkmeedan
genesi
biotech
taiwan
correspond
ntermin
autocleavag
site
sar
pro
chang
fluoresc
intens
monitor
cari
eclips
fluoresc
spectrophotomet
varian
nm
excit
emiss
wavelength
respect
kinet
measur
perform
c
buffer
contain
mm
sodium
phosphat
ph
mm
sodium
chlorid
mm
edta
mm
tcep
inhibit
constant
k
determin
measur
appar
kinet
paramet
constant
substrat
concentr
vari
inhibitor
concentr
mm
proteas
final
concentr
mm
incub
inhibitor
min
room
temperatur
reaction
initi
ad
substrat
volum
correspond
final
concentr
mm
reaction
mixtur
depend
activ
inhibitor
concentr
analyz
manner
similar
report
earlier
briefli
kinet
paramet
determin
global
nonlinear
regress
analysi
equat
v
v
rate
substrat
cleavag
presenc
absenc
inhibitor
respect
v
max
maxim
rate
substrat
concentr
inhibitor
concentr
k
micha
constant
